Frank Stenner
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 43
- Cancer Immunotherapy and Biomarkers 8
- Neutropenia and Cancer Infections 7
- Co-authors
- Michael Pfreundschuh (4 shared papers)Uğur Şahin (3 shared papers)Ö. Türeci (2 shared papers)Guorong Luo (3 shared papers)Rudolf Schmits (1 shared paper)B. Cochlovius (1 shared paper)Tanja Johannes (1 shared paper)Holger Schmitt (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Swiss Medical Weekly (7 papers)Annals of Oncology (6 papers)Oncology (4 papers)PLoS ONE (3 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Frank Stenner
105 papers receiving 3.4k citations
Frank Stenner's Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology 1.1k
- Oncology 959
- Radiology, Nuclear Medicine and Imaging 498
- Molecular Biology 1.2k
- Cancer Research 235
Countries citing papers authored by Frank Stenner
This map shows the geographic impact of Frank Stenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Stenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Stenner more than expected).
Fields of papers citing papers by Frank Stenner
This network shows the impact of papers produced by Frank Stenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Stenner. The network helps show where Frank Stenner may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Stenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human neoplasms elicit multiple specific immune responses in the autologous host. Hit paper breakdown → | 1995 | 894 |
| 2 | The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. | 1996 | 206 |
| 3 | 2006 | 182 | |
| 4 | 2009 | 108 | |
| 5 | 2013 | 107 | |
| 6 | 2005 | 99 | |
| 7 | 2010 | 99 | |
| 8 | 2018 | 90 | |
| 9 | 2009 | 89 | |
| 10 | 2002 | 83 | |
| 11 | 2016 | 66 | |
| 12 | 2010 | 63 | |
| 13 | 2004 | 60 | |
| 14 | 2017 | 57 | |
| 15 | 2008 | 56 | |
| 16 | 2001 | 56 | |
| 17 | 2016 | 53 | |
| 18 | 2007 | 53 | |
| 19 | 2003 | 48 | |
| 20 | 2011 | 46 |
About Frank Stenner
Frank Stenner is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 110 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (8 papers), Bladder and Urothelial Cancer Treatments (8 papers), Neutropenia and Cancer Infections (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (959 citations), Radiology, Nuclear Medicine and Imaging (498 citations), Molecular Biology (1.2k citations) and Cancer Research (235 citations). Frank Stenner has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Michael Pfreundschuh, Uğur Şahin, Ö. Türeci, Guorong Luo, Rudolf Schmits, B. Cochlovius, Tanja Johannes, Holger Schmitt, Heike Liewen and Christoph Renner. Their work appears in journals such as Journal of Clinical Oncology, Swiss Medical Weekly, Annals of Oncology, Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.